QTMeds

Drug Database Monograph

MINJUVI 200 mg

PENDING REVIEW

Active Ingredient: TAFASITAMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 65488266

← Back to Prescription Analyzer